Authors:
LAZARUS SC
LEE T
KEMP JP
WENZEL S
DUBE LM
OCHS RF
CARPENTIER PJ
LANCASTER JF
Citation: Sc. Lazarus et al., SAFETY AND CLINICAL EFFICACY OF ZILEUTON IN PATIENTS WITH CHRONIC ASTHMA, American journal of managed care, 4(6), 1998, pp. 841-848
Authors:
LEHNIGK B
RABE KF
DENT G
HERST RS
CARPENTIER PJ
MAGNUSSEN H
Citation: B. Lehnigk et al., EFFECTS OF A 5-LIPOXYGENASE INHIBITOR, ABT-761, ON EXERCISE-INDUCED BRONCHOCONSTRICTION AND URINARY LTE4 IN ASTHMATIC-PATIENTS, The European respiratory journal, 11(3), 1998, pp. 617-623
Authors:
DUBUSKE LM
GROSSMAN J
DUBE LM
SWANSON LJ
LANCASTER JF
BERGER W
CHAROUS BL
CRINER G
DAUL C
EDWARDS T
FINK JN
FLESCHER J
HOWLAND WC
KAISER HB
KORENBLAT PE
KUSSIN PS
LANG D
LIGHT R
NATHAN R
PIEN L
PLATTSMILLS TAE
RAMSDELL J
SCARDELLA AT
SCHENKEL EJ
SELNER J
SILVERS WS
CARPENTIER PJ
SWANSON SW
MANSKI RP
RUFF DD
Citation: Lm. Dubuske et al., RANDOMIZED TRIAL OF ZILEUTON IN PATIENTS WITH MODERATE ASTHMA - EFFECT OF REDUCED DOSING FREQUENCY AND AMOUNTS ON PULMONARY-FUNCTION AND ASTHMA SYMPTOMS, American journal of managed care, 3(4), 1997, pp. 633-640
Citation: J. Vanschoor et al., THE EFFECT OF ABT-761, A NOVEL 5-LIPOXYGENASE INHIBITOR, ON EXERCISE-INDUCED AND ADENOSINE-INDUCED BRONCHOCONSTRICTION IN ASTHMATIC SUBJECTS, American journal of respiratory and critical care medicine, 155(3), 1997, pp. 875-880
Authors:
KURTH K
TUNN U
AY R
SCHRODER FH
PAVONEMACALUSO M
DEBRUYNE F
TENKATE F
DEPAUW M
SYLVESTER R
ESSED E
CAUBERGH RV
HOEKSTRA JW
DEVOOGT HJ
NEWLING DWW
DEREIJKE TM
MENSINK HJA
GROEN JM
JAKSE G
LEISINGER HJ
RICHARDS B
ADIB RA
ROBINSON M
DENIS L
BOUFFIOUX C
SCHULMAN C
CARPENTIER PJ
Citation: K. Kurth et al., ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - LONG-TERM RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN, ETHOGLUCID AND TRANSURETHRAL RESECTION ALONE, The Journal of urology, 158(2), 1997, pp. 378-384